A clinical study in men with type 2 diabetes who developed partial testosterone deficiency showed testosterone immunosuppressive activity in reducing the synthesis of the proinflammatory cytokines IL-1β, IL-6 and TNF-α, an effect that persists after termination of testosterone treatment. This evidence concerns the gene TNF and type 2 diabetes mellitus.